Vanguard Group
RGNX icon

Vanguard Group’s Regenxbio RGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$28.1M Sell
3,421,192
-51,796
-1% -$425K ﹤0.01% 2394
2025
Q1
$24.8M Buy
3,472,988
+487,036
+16% +$3.48M ﹤0.01% 2411
2024
Q4
$23.1M Sell
2,985,952
-1,383,039
-32% -$10.7M ﹤0.01% 2521
2024
Q3
$45.8M Sell
4,368,991
-744,791
-15% -$7.81M ﹤0.01% 2219
2024
Q2
$59.8M Buy
5,113,782
+236,901
+5% +$2.77M ﹤0.01% 2074
2024
Q1
$103M Buy
4,876,881
+436,043
+10% +$9.19M ﹤0.01% 1850
2023
Q4
$79.7M Buy
4,440,838
+64,265
+1% +$1.15M ﹤0.01% 1973
2023
Q3
$72M Buy
4,376,573
+36,531
+0.8% +$601K ﹤0.01% 1967
2023
Q2
$86.8M Buy
4,340,042
+23,021
+0.5% +$460K ﹤0.01% 1929
2023
Q1
$81.6M Buy
4,317,021
+44,527
+1% +$842K ﹤0.01% 1919
2022
Q4
$96.9M Buy
4,272,494
+4,952
+0.1% +$112K ﹤0.01% 1823
2022
Q3
$113M Buy
4,267,542
+15,219
+0.4% +$402K ﹤0.01% 1720
2022
Q2
$105M Buy
4,252,323
+181,861
+4% +$4.49M ﹤0.01% 1793
2022
Q1
$135M Buy
4,070,462
+16,496
+0.4% +$548K ﹤0.01% 1772
2021
Q4
$133M Buy
4,053,966
+44,784
+1% +$1.46M ﹤0.01% 1828
2021
Q3
$168M Buy
4,009,182
+65,423
+2% +$2.74M ﹤0.01% 1702
2021
Q2
$153M Buy
3,943,759
+7,527
+0.2% +$292K ﹤0.01% 1771
2021
Q1
$134M Buy
3,936,232
+600,934
+18% +$20.5M ﹤0.01% 1795
2020
Q4
$151M Buy
3,335,298
+88,200
+3% +$4M ﹤0.01% 1621
2020
Q3
$89.4M Sell
3,247,098
-203,269
-6% -$5.59M ﹤0.01% 1742
2020
Q2
$127M Sell
3,450,367
-94,538
-3% -$3.48M ﹤0.01% 1553
2020
Q1
$115M Buy
3,544,905
+123,805
+4% +$4.01M ﹤0.01% 1449
2019
Q4
$140M Buy
3,421,100
+229,397
+7% +$9.4M ﹤0.01% 1585
2019
Q3
$114M Sell
3,191,703
-258,171
-7% -$9.19M ﹤0.01% 1653
2019
Q2
$177M Buy
3,449,874
+44,452
+1% +$2.28M 0.01% 1432
2019
Q1
$195M Buy
3,405,422
+17,318
+0.5% +$992K 0.01% 1358
2018
Q4
$142M Buy
3,388,104
+582,135
+21% +$24.4M 0.01% 1461
2018
Q3
$212M Buy
2,805,969
+947,671
+51% +$71.5M 0.01% 1343
2018
Q2
$133M Buy
1,858,298
+573,718
+45% +$41.2M 0.01% 1629
2018
Q1
$38.3M Buy
1,284,580
+61,860
+5% +$1.85M ﹤0.01% 2204
2017
Q4
$40.7M Buy
1,222,720
+9,922
+0.8% +$330K ﹤0.01% 2167
2017
Q3
$40M Buy
1,212,798
+130,337
+12% +$4.29M ﹤0.01% 2155
2017
Q2
$21.4M Buy
1,082,461
+100,944
+10% +$1.99M ﹤0.01% 2420
2017
Q1
$18.9M Buy
981,517
+184,700
+23% +$3.56M ﹤0.01% 2462
2016
Q4
$14.8M Buy
796,817
+30,502
+4% +$566K ﹤0.01% 2559
2016
Q3
$10.7M Buy
766,315
+196,380
+34% +$2.75M ﹤0.01% 2654
2016
Q2
$4.56M Buy
569,935
+306,596
+116% +$2.45M ﹤0.01% 3034
2016
Q1
$2.84M Buy
263,339
+60,017
+30% +$648K ﹤0.01% 3233
2015
Q4
$3.38M Buy
203,322
+173,356
+579% +$2.88M ﹤0.01% 3178
2015
Q3
$660K Buy
+29,966
New +$660K ﹤0.01% 3763